Windels Marx Lane Mittendorf

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases113

Challenger50%

Patent Owner50%

NPE50%

windels-marx

windelsmarx.com

Practice Areas

BiotechCommunicationsTransport., E-Comm.

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
09/16/24	Abbvie Inc v. Alkem Laboratories Ltd 1:22-CV-01423 ( D. DE )	SO ORDERED, re [273] Stipulation and Order to Extend Expert Reports and Daubert Motions Deadlines. (Reset Scheduling Order Deadlines: Opening Expert Reports due by 11/14/2024; Rebuttal Expert Reports due by 1/23/2025; Reply Expert Reports due by 2/14/2025; Close of Expert Discovery on 4/10/2025; Daubert Motions due by 4/17/2025). Signed by Judge Jennifer L. Hall on 9/16/2024. (ceg) (Entered: 09/16/2024) SO ORDERED, re [273] Stipulation and Order to Extend Expert Reports and Daubert Motions Deadlines. (Reset Scheduling Order Deadlines: Opening Expert Reports due by 11/14/2024; Rebuttal Expert Reports due by 1/23/2025; Reply Expert Reports due by 2/14/2025; Close of Expert Discovery on 4/10/2025; Daubert Motions due by 4/17/2025). Signed by Judge Jennifer L. Hall on 9/16/2024. (ceg) (Entered: 09/16/2024)
09/16/24	In re: Entresto (Sacubitril/Valsartan) Patent Litigation 1:20-MD-02930 ( D. DE )	REDACTED VERSION of [1528] Letter, by Gerbera Therapeutics Inc., Nanjing Noratech Pharmaceutical Co., Limited. (Attachments: # [1] Exhibit G, # [2] Exhibit H, # [3] Exhibit I)(Gattuso, Dominick) (Entered: 09/16/2024)
09/16/24	In re: Entresto (Sacubitril/Valsartan) Patent Litigation 1:20-MD-02930 ( D. DE )	DEFICIENCY NOTICE by the Court issued to Gerbera Therapeutics, Inc. and Nanjing Noratech Pharmaceutical Co. Limited re [1539] Redacted Document. Upon review it was determined this filing was not a complete version of what was filed at D.I. [1528] . The redaction lacked Exhibit I. Defendants are to file a revised redacted version of D.I. [1528] no later than three (3) days from the date of this notice. (nms) (Entered: 09/16/2024) DEFICIENCY NOTICE by the Court issued to Gerbera Therapeutics, Inc. and Nanjing Noratech Pharmaceutical Co. Limited re [1539] Redacted Document. Upon review it was determined this filing was not a complete version of what was filed at D.I. [1528] . The redaction lacked Exhibit I. Defendants are to file a revised redacted version of D.I. [1528] no later than three (3) days from the date of this notice. (nms) (Entered: 09/16/2024)
09/16/24	In re: Xarelto (Rivaroxaban) ('310) Patent Litigation 1:21-MD-03017 ( D. DE )	REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # [297] . (nms) (Entered: 09/16/2024)
09/12/24	Abbvie Inc v. DR Reddys Laboratories Ltd 1:20-CV-00968 ( D. DE )	ORDER, Counsel shall meet and confer and shall jointly file a proposed scheduling order for the Court's consideration by September 27, 2024. This order shall include the dates for the final pre-trial order, the pre-trial conference, trial, and the parties' modified plan to simplify this matter (narrowing of claims) as discussed in the conference. Additionally, it is ORDERED that the final pre-trial order shall contained the parties' understanding of this case's preclusive effect on claims asserted in the complaint, but not litigated at trial. Signed by Judge Mitchell S. Goldberg on 9/12/2024. (jfm) (Entered: 09/12/2024) ORDER, Counsel shall meet and confer and shall jointly file a proposed scheduling order for the Court's consideration by September 27, 2024. This order shall include the dates for the final pre-trial order, the pre-trial conference, trial, and the parties' modified plan to simplify this matter (narrowing of claims) as discussed in the conference. Additionally, it is ORDERED that the final pre-trial order shall contained the parties' understanding of this case's preclusive effect on claims asserted in the complaint, but not litigated at trial. Signed by Judge Mitchell S. Goldberg on 9/12/2024. (jfm) (Entered: 09/12/2024)
09/13/24	Abbvie Inc v. DR Reddys Laboratories Ltd 1:20-CV-00968 ( D. DE )	Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Status Conference held on 9/12/2024. Plaintiffs' Counsel: Chad J. Peterman and Michelle Streifthau-Livizos. Defenses' Counsel: Neal Belgam, Brandon White, Daniel Tayler, Anne Shea Gaza, Adam C. LaRock, and Samantha G. Wilson. (Court Reporter Maureen McHugh.) (mpb) (Entered: 09/13/2024)
09/09/24	Bausch & Lomb Inc v. Slayback Pharma LLC 3:21-CV-16766 ( D. NJ )	Set Deadlines as to [398] MOTION to Seal Document [356] Letter,, [363] Letter,, [346] Letter,,, [359] Stipulation and Order, [368] Letter,, [350] Letter, [341] Letter,, [345] Letter,, [361] Letter,, [362] Transcript, [360] Stipulation and Order, [335] Letter,, [35. Motion set for 10/7/2024 before Magistrate Judge Rukhsanah L. Singh. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (jal, ) (Entered: 09/09/2024) Set Deadlines as to [398] MOTION to Seal Document [356] Letter,, [363] Letter,, [346] Letter,,, [359] Stipulation and Order, [368] Letter,, [350] Letter, [341] Letter,, [345] Letter,, [361] Letter,, [362] Transcript, [360] Stipulation and Order, [335] Letter,, [35. Motion set for 10/7/2024 before Magistrate Judge Rukhsanah L. Singh. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (jal, ) (Entered: 09/09/2024)
09/09/24	Bausch & Lomb Inc v. Gland Pharma Ltd 3:22-CV-04345 ( D. NJ )	Pro Hac Vice counsel, Rebecca Lynne Neubauer, has been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (jal, ) (Entered: 09/09/2024)
09/06/24	Bayer Pharma AG v. Lupin Ltd 1:21-CV-00314 ( D. DE )	Joint Status Report Regarding Stay, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Bayer Intellectual Property GMBH. (Fahnestock, Derek) Modified on 9/6/2024 (nms). (Entered: 09/06/2024)
09/06/24	Bayer Pharma AG v. DR Reddy's Laboratories Ltd 1:23-CV-00410 ( D. DE )	Joint Status Report Regarding Stay, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Bayer Intellectual Property GMBH. (Fahnestock, Derek) Modified on 9/6/2024 (nms). (Entered: 09/06/2024)